Vidyadhar M. Paradkar

Discovery of Dinaciclib (SCH 727965): A Potent and Selective Inhibitor of Cyclin-Dependent Kinases

Kamil Paruch, Michael P. Dwyer, Carmen Álvarez et al. · ACS Medicinal Chemistry Letters · 2010 · 174 citations · Full text

Drug Target, Pathology, Chemical Biology +21

Design, Synthesis, and Activity of 2-Imidazol-1-ylpyrimidine Derived Inducible Nitric Oxide Synthase Dimerization Inhibitors

David D. Davey, Marc Adler, Damian O. Arnaiz et al. · Journal of Medicinal Chemistry · 2007 · 67 citations · Full text

Combinatorial Chemistry, Medicinal Chemistry, Biochemistry +14

Pyrazolo[1,5-a]pyrimidines as orally available inhibitors of cyclin-dependent kinase 2

Kamil Paruch, Michael P. Dwyer, Carmen Álvarez et al. · Bioorganic & Medicinal Chemistry Letters · 2007 · 65 citations · Full text

Cyclin-dependent Kinase 2, Biochemistry, Medicine +5

Small molecule antagonists of the bradykinin B1 receptor

Robert A. Horlick, Michael Ohlmeyer, Ilana L. Stroke et al. · Immunopharmacology · 1999 · 29 citations

Molecular Physiology, Biochemistry, Medicine +8

2-Benzimidazolyl-9-(chroman-4-yl)-purinone derivatives as JAK3 inhibitors

Andrew G. Cole, Adolph C. Bohnstedt, Vidyadhar M. Paradkar et al. · Bioorganic & Medicinal Chemistry Letters · 2009 · 18 citations · Full text

Medicinal Chemistry, Biochemistry, Medicine +8